InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Twist Bioscience Corp

TWST Clue Score57
United States Fiscal year ends September CIK 0001581280
$159.78 +5.08% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $159.78 +57.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 31 Oct 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue10.8Operating income−58.5Net income−59.3Fiscal year 2018Revenue25.4 +136.2%Operating income−70.6Net income−71.2Fiscal year 2019Revenue54.4 +113.9%Operating income−108.9Net income−107.7Fiscal year 2020Revenue90.1 +65.7%Operating income−140.1Net income−139.9EPS, diluted−3.57Fiscal year 2021Revenue132.3 +46.9%Operating income−152.7Net income−152.1EPS, diluted−3.15Fiscal year 2022Revenue203.6 +53.8%Operating income−234.8Net income−217.9EPS, diluted−4.04Fiscal year 2023Revenue245.1 +20.4%Operating income−217.2Net income−204.6EPS, diluted−3.60Fiscal year 2024Revenue313.0 +27.7%Operating income−220.8Net income−208.7EPS, diluted−3.60Fiscal year 2025Revenue376.6 +20.3%Operating income−136.3Net income−77.7EPS, diluted−1.30
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 10.8 25.4 54.4 90.1 132.3 203.6 245.1 313.0 376.6
Growth +136.2% +113.9% +65.7% +46.9% +53.8% +20.4% +27.7% +20.3%
Operating income −58.5 −70.6 −108.9 −140.1 −152.7 −234.8 −217.2 −220.8 −136.3
Net income −59.3 −71.2 −107.7 −139.9 −152.1 −217.9 −204.6 −208.7 −77.7
Growth
EPS, diluted n/a n/a n/a −3.57 −3.15 −4.04 −3.60 −3.60 −1.30
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−543.2%Net margin−550.8%Free cash flow margin−537.7%Fiscal year 2018Operating margin−277.5%Net margin−280.2%Free cash flow margin−274.7%Fiscal year 2019Operating margin−200.1%Net margin−198.0%Free cash flow margin−188.8%Fiscal year 2020Operating margin−155.5%Net margin−155.3%Free cash flow margin−168.8%Fiscal year 2021Operating margin−115.4%Net margin−114.9%Free cash flow margin−105.3%Fiscal year 2022Operating margin−115.3%Net margin−107.0%Free cash flow margin−111.1%Fiscal year 2023Operating margin−88.6%Net margin−83.5%Free cash flow margin−69.5%Fiscal year 2024Operating margin−70.6%Net margin−66.7%Free cash flow margin−22.1%Fiscal year 2025Operating margin−36.2%Net margin−20.6%Free cash flow margin−20.1%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −543.2% −277.5% −200.1% −155.5% −115.4% −115.3% −88.6% −70.6% −36.2%
Net margin −550.8% −280.2% −198.0% −155.3% −114.9% −107.0% −83.5% −66.7% −20.6%
Free cash flow margin −537.7% −274.7% −188.8% −168.8% −105.3% −111.1% −69.5% −22.1% −20.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−51.3Capital expenditure−6.6Free cash flow−57.9Fiscal year 2018Operating cash flow−66.2Capital expenditure−3.7Free cash flow−69.9Fiscal year 2019Operating cash flow−87.9Capital expenditure−14.8Free cash flow−102.7Fiscal year 2020Operating cash flow−142.3Capital expenditure−9.9Free cash flow−152.1Fiscal year 2021Operating cash flow−112.2Capital expenditure−27.1Free cash flow−139.3Fiscal year 2022Operating cash flow−124.4Capital expenditure−101.9Free cash flow−226.2Fiscal year 2023Operating cash flow−142.5Capital expenditure−27.8Free cash flow−170.3Fiscal year 2024Operating cash flow−64.1Capital expenditure−5.1Free cash flow−69.2Fiscal year 2025Operating cash flow−47.6Capital expenditure−28.0Free cash flow−75.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −51.3 −66.2 −87.9 −142.3 −112.2 −124.4 −142.5 −64.1 −47.6
Capital expenditure −6.6 −3.7 −14.8 −9.9 −27.1 −101.9 −27.8 −5.1 −28.0
Free cash flow −57.9 −69.9 −102.7 −152.1 −139.3 −226.2 −170.3 −69.2 −75.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash31.2Shareholders’ equity−133.4Fiscal year 2018Cash80.8Total debt9.7Net cash (debt)71.0Shareholders’ equity−201.4Fiscal year 2019Cash46.7Total debt7.7Net cash (debt)39.0Shareholders’ equity152.1Debt to equity0.05Fiscal year 2020Cash93.7Total debt4.7Net cash (debt)88.9Shareholders’ equity336.3Debt to equity0.01Fiscal year 2021Cash465.8Total debt1.6Net cash (debt)464.3Shareholders’ equity580.8Debt to equity0.00Fiscal year 2022Cash378.7Total debt0.0Net cash (debt)378.7Shareholders’ equity789.4Debt to equity0.00Fiscal year 2023Cash286.5Shareholders’ equity623.4Fiscal year 2024Cash226.3Shareholders’ equity472.7Fiscal year 2025Cash183.0Shareholders’ equity473.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 31.2 80.8 46.7 93.7 465.8 378.7 286.5 226.3 183.0
Total debt n/a 9.7 7.7 4.7 1.6 0.0 n/a n/a n/a
Net cash (debt) n/a 71.0 39.0 88.9 464.3 378.7 n/a n/a n/a
Shareholders’ equity −133.4 −201.4 152.1 336.3 580.8 789.4 623.4 472.7 473.0
Debt to equity n/a n/a 0.05 0.01 0.00 0.00 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Sep 2017 FY2018 30 Sep 2018 FY2019 30 Sep 2019 FY2020 30 Sep 2020 FY2021 30 Sep 2021 FY2022 30 Sep 2022 FY2023 30 Sep 2023 FY2024 30 Sep 2024 FY2025 30 Sep 2025
Revenue and profit
10.8 25.4 54.4 90.1 132.3 203.6 245.1 313.0 376.6
Growth +136.2% +113.9% +65.7% +46.9% +53.8% +20.4% +27.7% +20.3%
24.0 32.2 47.4 61.4 80.6 119.3 155.4 179.6 185.6
19.2 20.3 35.7 43.0 69.1 120.3 106.9 90.9 80.3
26.1 43.5 80.1 103.3 135.9 212.9 189.7 218.4 247.0
−58.5 −70.6 −108.9 −140.1 −152.7 −234.8 −217.2 −220.8 −136.3
Growth
−59.0 −71.0 −107.4 −139.5 −154.0 −228.3 −203.5 −208.2 −77.0
0.3 0.2 0.3 0.4 −1.9 −10.4 1.2 0.6 0.7
−59.3 −71.2 −107.7 −139.9 −152.1 −217.9 −204.6 −208.7 −77.7
Growth
Per share
n/a n/a n/a −3.57 −3.15 −4.04 −3.60 −3.60 −1.30
n/a n/a n/a −3.57 −3.15 −4.04 −3.60 −3.60 −1.30
Growth
n/a n/a n/a 39.2 48.3 53.9 56.9 58.0 59.8
n/a n/a n/a 39.2 48.3 53.9 56.9 58.0 59.8
Growth +23.1% +11.7% +5.6% +2.0% +3.1%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 33.1% a year over five years.
  • The diluted share count rose 52.6% in five years, which is dilution.
  • Operating margin is up 119.3 points on five years ago, at -36.2%.
  • A net loss in 9 of 9 years on file.